FOSL1 and cancer: Fra-1 triggers a switch in the expression of EMT inducers, involving the ZEB2 and SNAI2 downregulation, associated with the upregulation of ZEB1 and TWIST1, which drive the cancer cell reprogramming leading to melanocyte dedifferentiation and gain of mesenchymal features [76].